Molecular Encoding of Ischemic Stroke and its Resolution after Human Neural Stem Cell Therapy by Extracellular Vesicles

Abstract

Extracellular vesicles (EVs) can cross the blood–brain barrier and enter the systemic circulation, potentially acting as peripheral biomarkers of stroke neuropathology. Here, we investigated alterations in EV RNA cargoes extracted from rat brain and plasma before and after stroke induction via middle cerebral artery occlusion and subsequent human neural stem cells (hNSCs) transplantation. EV RNA coexpression profiles were assessed, and digital source tracking was used to determine EV origin. The therapeutic effects of intra-arterial delivery of hNSCs on ischemic rat brains were quantified, focusing on functional recovery, resolution of ischemic lesions, and the microenvironment. Stroke induced distinct EV secretion patterns, with a notable increase in EV secretion from non-neuronal cells. hNSCs transplantation caused minimal immune rejection and transplanted cells survived in the brain for over a week. Stem cell-derived EVs were detected in peripheral blood, indicating prolonged systemic distribution after transplantation. Gene regulatory network analyses identified specific EV miRNAs that play crucial roles in neurogenesis, wound healing, angiogenesis, and blood–brain barrier integrity. An integrated analysis of EV RNAs in brain and plasma samples revealed that stroke increased correlations in RNA expression between brain and plasma and that hNSCs transplantation reversed the effect. Brain- and plasma-derived EVs carry similar molecular information after stroke, suggesting that plasma-derived EV RNAs reflect stroke pathophysiology. Intra-arterial transplantation of hNSCs improved outcomes after stroke in rats, by promoting endogenous neurogenesis and maintaining blood–brain barrier integrity. The identified EV miRNAs provided a new mechanism by which hNSCs transplantation regulates neural regeneration through the miR-204-5p/EFNB3 axis.

References

[1] G. van Niel, G. D'Angelo, and G. Raposo, “Shedding Light on the Cell Biology of Extracellular Vesicles,” Nature Reviews Molecular Cell Biology 19, no. 4 (2018): 213-228.

[2] M. Shi, L. Sheng, T. Stewart, C. P. Zabetian, and J. Zhang, “New Windows Into the Brain: Central Nervous System-derived Extracellular Vesicles in Blood,” Progress in Neurobiology 175 (2019): 96-106.

[3] E. J. Goetzl, M. Mustapic, D. Kapogiannis, et al., “Cargo Proteins of Plasma Astrocyte-derived Exosomes in Alzheimer's Disease,” Faseb Journal 30, no. 11 (2016): 3853-3859.

[4] M. Shi, C. Liu, T. J. Cook, et al., “Plasma Exosomal α-synuclein Is Likely CNS-derived and Increased in Parkinson's Disease,” Acta Neuropathologica 128, no. 5 (2014): 639-650.

[5] C. Chang, Y. Wang, R. Wang, and X. Bao, “Considering Context-Specific microRNAs in Ischemic Stroke With Three “W”: Where, When, and What,” Molecular Neurobiology 61, no. 10 (2024): 7335-7353.

[6] Global, Regional, and National Burden of Stroke, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016. Lancet Neurology 2019; 18(5): 439-458.

[7] J. M. Roth, “Recombinant Tissue Plasminogen Activator for the Treatment of Acute Ischemic Stroke,” Proceedings (Baylor University Medical Center) 24, no. 3 (2011): 257-259.

[8] L. Huang and L. Zhang, “Neural Stem Cell Therapies and Hypoxic-ischemic Brain Injury,” Progress in Neurobiology 173 (2019): 1-17.

[9] M. Kawabori, H. Shichinohe, S. Kuroda, and K. Houkin, “Clinical Trials of Stem Cell Therapy for Cerebral Ischemic Stroke,” International Journal of Molecular Sciences 21, no. 19 (2020): 7380.

[10] D. Kalladka, J. Sinden, K. Pollock, et al., “Human Neural Stem Cells in Patients With Chronic Ischaemic Stroke (PISCES): A Phase 1, First-in-man Study,” Lancet 388, no. 10046 (2016): 787-796.

[11] K. W. Muir, D. Bulters, M. Willmot, et al., “Intracerebral Implantation of human Neural Stem Cells and Motor Recovery After Stroke: Multicentre Prospective Single-arm Study (PISCES-2),” Journal of Neurology, Neurosurgery, and Psychiatry 91, no. 4 (2020): 396-401.

[12] Y. F. Liu, H. T. Liu, C. Chang, et al., “Stereotactically Intracerebral Transplantation of Neural Stem Cells for Ischemic Stroke Attenuated Inflammatory Responses and Promoted Neurogenesis: An Experimental Study With Monkeys,” International Journal of Surgery 110, no. 9 (2024): 5417-5433.

[13] P. Yuan, L. Ding, H. Chen, et al., “Neural Stem Cell-Derived Exosomes Regulate Neural Stem Cell Differentiation through miR-9-Hes1 Axis,” Frontiers in Cell and Developmental Biology 9 (2021): 601600.

[14] T. Tian, L. Cao, C. He, et al., “Targeted Delivery of Neural Progenitor Cell-derived Extracellular Vesicles for Anti-inflammation After Cerebral Ischemia,” Theranostics 11, no. 13 (2021): 6507-6521.

[15] Z. Qi, Y. Zhao, Y. Su, et al., “Serum Extracellular Vesicle-Derived miR-124-3p as a Diagnostic and Predictive Marker for Early-Stage Acute Ischemic Stroke,” Frontiers in Molecular Biosciences 8 (2021): 685088.

[16] E. Tortosa, C. Montenegro-Venegas, M. Benoist, et al., “Microtubule-associated Protein 1B (MAP1B) Is Required for Dendritic Spine Development and Synaptic Maturation,” Journal of Biological Chemistry 286, no. 47 (2011): 40638-40648.

[17] Z. Wei, A. O. Batagov, S. Schinelli, et al., “Coding and Noncoding Landscape of Extracellular RNA Released by human Glioma Stem Cells,” Nature Communications 8, no. 1 (2017): 1145-1145.

[18] B. Manwani, N. Brathaban, A. Baqai, et al., “Small RNA Signatures of Acute Ischemic Stroke in L1CAM Positive Extracellular Vesicles,” Scientific Reports 14, no. 1 (2024): 13560-13560.

[19] I. Kern, R. Xu, S. Julien, et al., “Embryonic Stem Cell-based Screen for Small Molecules: Cluster Analysis Reveals Four Response Patterns in Developing Neural Cells,” Current Medicinal Chemistry 20, no. 5 (2013): 710-723.

[20] L. Huang, L. Hua, and X. Zhang, “The Exosomal MicroRNA Profile Is Responsible for the Mesenchymal Stromal Cell Transplantation-Induced Improvement of Functional Recovery After Stroke in Rats,” Neuroimmunomodulation 29, no. 2 (2021): 151-160.

[21] L. Garcia-Bonilla, Z. Shahanoor, R. Sciortino, et al., “Analysis of Brain and Blood Single-cell Transcriptomics in Acute and Subacute Phases After Experimental Stroke,” Nature Immunology 25, no. 2 (2024): 357-370.

[22] D. M. Hermann, W. Xin, M. Bähr, B. Giebel, and T. R. Doeppner, “Emerging Roles of Extracellular Vesicle-associated Non-coding RNAs in Hypoxia: Insights From Cancer, Myocardial Infarction and Ischemic Stroke,” Theranostics 12, no. 13 (2022): 5776-5802.

[23] R. Brouns, B. De Vil, P. Cras, et al., “Neurobiochemical Markers of Brain Damage in Cerebrospinal Fluid of Acute Ischemic Stroke Patients,” Clinical Chemistry 56, no. 3 (2010): 451-458.

[24] Z. P. Chen, S. Wang, X. Zhao, et al., “Lipid-accumulated Reactive Astrocytes Promote Disease Progression in Epilepsy,” Nature Neuroscience 26, no. 4 (2023): 542-554.

[25] W. Wang, D. B. Li, R. Y. Li, et al., “Diagnosis of Hyperacute and Acute Ischaemic Stroke: The Potential Utility of Exosomal MicroRNA-21-5p and MicroRNA-30a-5p,” Cerebrovascular Diseases 45, no. 5-6 (2018): 204-212.

[26] Q. Wang, F. Wang, F. Fu, et al., “Diagnostic and Prognostic Value of Serum miR-9-5p and miR-128-3p Levels in Early-stage Acute Ischemic Stroke,” Clinics (Sao Paulo) 76 (2021): e2958.

[27] T. Kim, S. L. Mehta, K. C. Morris-Blanco, et al., “The microRNA miR-7a-5p Ameliorates Ischemic Brain Damage by Repressing α-synuclein,” Science Signaling 11, no. 560 (2018): eaat4285.

[28] C. S. Shi, Q. Hu, S. L. Fang, C. X. Sun, and D. H. Shao, “MicroRNA-204-5p Ameliorates Neurological Injury via the EphA4/PI3K/AKT Signaling Pathway in Ischemic Stroke,” Acs Chemical Neuroscience 14, no. 11 (2023): 2060-2073.

[29] S. E. McGeary, K. S. Lin, C. Y. Shi, et al., “The Biochemical Basis of microRNA Targeting Efficacy,” Science 366, no. 6472 (2019): eaav1741.

[30] Y. Chen and X. Wang, “miRDB: An Online Database for Prediction of Functional microRNA Targets,” Nucleic Acids Research 48, no. D1 (2020): D127-D131.

[31] G. Skoufos, P. Kakoulidis, S. Tastsoglou, et al., “TarBase-v9.0 Extends Experimentally Supported miRNA-gene Interactions to Cell-types and Virally Encoded miRNAs,” Nucleic Acids Research 52, no. D1 (2024): D304-D310.

[32] J. G. Flanagan and P. Vanderhaeghen, “The Ephrins and Eph Receptors in Neural Development,” Annual Review of Neuroscience 21 (1998): 309-345.

[33] S. Wegner, R. Uhlemann, V. Boujon, et al., “Endothelial Cell-Specific Transcriptome Reveals Signature of Chronic Stress Related to Worse Outcome after Mild Transient Brain Ischemia in Mice,” Molecular Neurobiology 57, no. 3 (2020): 1446-1458.

[34] H. Jiang, J. F. Toscano, S. S. Song, et al., “Differential Expression of Circulating Exosomal microRNAs in Refractory Intracranial Atherosclerosis Associated With Antiangiogenesis,” Scientific Reports 9, no. 1 (2019): 19429.

[35] R. H. Andres, R. Choi, A. V. Pendharkar, et al., “The CCR2/CCL2 Interaction Mediates the Transendothelial Recruitment of Intravascularly Delivered Neural Stem Cells to the Ischemic Brain,” Stroke; A Journal of Cerebral Circulation 42, no. 10 (2011): 2923-2931.

[36] D. D. Namestnikova, I. L. Gubskiy, V. A. Revkova, et al., “Intra-Arterial Stem Cell Transplantation in Experimental Stroke in Rats: Real-Time MR Visualization of Transplanted Cells Starting with Their First Pass through the Brain with Regard to the Therapeutic Action,” Frontiers in Neuroscience 15 (2021): 641970.

[37] P. Xiang, J. Hu, H. Wang, et al., “miR-204-5p Is Sponged by TUG1 to Aggravate Neuron Damage Induced by Focal Cerebral Ischemia and Reperfusion Injury Through Upregulating COX2,” Cell Death Discovery 8, no. 1 (2022): 89.

[38] J. Ricard, J. Salinas, L. Garcia, and D. J. Liebl, “EphrinB3 regulates Cell Proliferation and Survival in Adult Neurogenesis,” Molecular and Cellular Neuroscience 31, no. 4 (2006): 713-722.

[39] T. R. Doeppner, E. Bretschneider, M. Doehring, et al., “Enhancement of Endogenous Neurogenesis in Ephrin-B3 Deficient Mice After Transient Focal Cerebral Ischemia,” Acta Neuropathologica 122, no. 4 (2011): 429-442.

[40] J. A. Welsh, D. C. I. Goberdhan, and L. O'Driscoll, “Minimal Information for Studies of Extracellular Vesicles (MISEV2023): From Basic to Advanced Approaches,” Journal of Extracellular Vesicles 13, no. 2 (2024): e12404.

[41] F. Lucien, D. Gustafson, M. Lenassi, et al., “MIBlood-EV: Minimal Information to Enhance the Quality and Reproducibility of Blood Extracellular Vesicle Research,” Journal of Extracellular Vesicles 12, no. 12 (2023): e12385-e12385.

[42] K. Cheng and R. Kalluri, “Guidelines for Clinical Translation and Commercialization of Extracellular Vesicles and Exosomes Based Therapeutics,” Extracellular Vesicle 2 (2023): 100029.

[43] R. Nieuwland and P. R. M. Siljander, “A Beginner's Guide to Study Extracellular Vesicles in human Blood Plasma and Serum,” Journal of Extracellular Vesicles 13, no. 1 (2024): e12400-e12400.

[44] Z. Luan, W. Liu, S. Qu, et al., “Effects of Neural Progenitor Cell Transplantation in Children With Severe Cerebral Palsy,” Cell Transplantation 21, no. Suppl 1 (2012): S91-S98.

[45] T. Chiang, R. O. Messing, and W. H. Chou, “Mouse Model of Middle Cerebral Artery Occlusion,” Journal of Visualized Experiments: JoVE 48 (2011): 2761.

[46] Y. Li, J. Chen, L. Wang, M. Lu, and M. Chopp, “Treatment of Stroke in Rat With Intracarotid Administration of Marrow Stromal Cells,” Neurology 56, no. 12 (2001): 1666-1672.

[47] A. N. Böing, E. van der Pol, A. E. Grootemaat, et al., “Single-step Isolation of Extracellular Vesicles by Size-exclusion Chromatography,” Journal of Extracellular Vesicles (2014): 3.

[48] L. J. Vella, B. J. Scicluna, L. Cheng, et al., “A Rigorous Method to Enrich for Exosomes From Brain Tissue,” Journal of Extracellular Vesicles 6, no. 1 (2017): 1348885.

[49] M. E. Ritchie, B. Phipson, D. Wu, et al., “limma Powers Differential Expression Analyses for RNA-sequencing and Microarray Studies,” Nucleic Acids Research 43, no. 7 (2015): e47.

[50] Y. Ru, K. J. Kechris, B. Tabakoff, et al., “The multiMiR R Package and Database: Integration of microRNA-target Interactions Along With Their Disease and Drug Associations,” Nucleic Acids Research 42, no. 17 (2014): e133.

[51] T. Wu, E. Hu, S. Xu, et al., “clusterProfiler 4.0: A Universal Enrichment Tool for Interpreting Omics Data,” Innovation (Camb) 2, no. 3 (2021): 100141.

[52] S. Hänzelmann, R. Castelo, and J. Guinney, “GSVA: Gene Set Variation Analysis for Microarray and RNA-seq Data,” BMC Bioinformatics [Electronic Resource] 14 (2013): 7.

[53] L. Kumar and M. EF, “Mfuzz: A Software Package for Soft Clustering of Microarray Data,” Bioinformation 2, no. 1 (2007): 5-7.

[54] I. Kerseviciute and J. Gordevicius, “aPEAR: An R Package for Autonomous Visualization of Pathway Enrichment Networks,” Bioinformatics 39, no. 11 (2023): btad672.

[55] A. Jain and G. Tuteja, “TissueEnrich: Tissue-specific Gene Enrichment Analysis,” Bioinformatics 35, no. 11 (2019): 1966-1967.

[56] Y. Yu, J. C. Fuscoe, C. Zhao, et al., “A Rat RNA-Seq Transcriptomic BodyMap Across 11 Organs and 4 Developmental Stages,” Nature Communications 5 (2014): 3230.

[57] D. J. Sokolowski, M. Faykoo-Martinez, L. Erdman, et al., “Single-cell Mapper (scMappR): Using scRNA-seq to Infer the Cell-type Specificities of Differentially Expressed Genes,” NAR Genom Bioinform 3, no. 1 (2021): lqab011.

[58] D. Bormann, M. Knoflach, E. Poreba, et al., “Single-nucleus RNA Sequencing Reveals Glial Cell Type-specific Responses to Ischemic Stroke in Male Rodents,” Nature Communications 15, no. 1 (2024): 6232.

[59] Z. Gu, R. Eils, and M. Schlesner, “Complex Heatmaps Reveal Patterns and Correlations in Multidimensional Genomic Data,” Bioinformatics 32, no. 18 (2016): 2847-2849.

[60] C. Ginestet, “ggplot2: Elegant Graphics for Data Analysis,” Journal of the Royal Statistical Society Series A: Statistics in Society 174, no. 1 (2011): 245-246.

[61] J. R. Conway, A. Lex, and N. Gehlenborg, “UpSetR: An R Package for the Visualization of Intersecting Sets and Their Properties,” Bioinformatics 33, no. 18 (2017): 2938-2940.

RIGHTS & PERMISSIONS

2025 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.